Polarean Imaging PLC
LSE:POLX
Relative Value
There is not enough data to reliably calculate the relative value of POLX.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
POLX Competitors Multiples
Polarean Imaging PLC Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Polarean Imaging PLC
LSE:POLX
|
965.6k GBP | 0.5 | -0.1 | 0.6 | 0.6 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
192B USD | 4.3 | 29.4 | 16.9 | 23.2 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
172.5B USD | 17.1 | 60.4 | 45.8 | 56.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
137.2B USD | 5.5 | 42.3 | 21.5 | 26 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
115.4B USD | 3.3 | 25 | 13.7 | 20 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
103.8B USD | 5.2 | 35.8 | 21 | 28.2 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
44.4B EUR | 1.9 | 21.2 | 11.8 | 16.6 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
49.8B USD | 8.2 | 46.4 | 25.6 | 28 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
47.7B USD | 11.1 | 45.1 | 32 | 35.4 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
46.7B USD | 2.1 | 26.6 | 10.4 | 17.5 | |
| US |
|
Resmed Inc
NYSE:RMD
|
36B USD | 6.7 | 24.2 | 17.1 | 19 |